]>
IRCT20160308026962N4 IRCT 2020-08-03 Oroumia University of Medical Sciences Investigating the effect of vitamin D and vitamin E on Intensity and Duration of Dysmenorrhea The Effect of Vitamin D and Vitamin E on Ameliorating Intensity and Duration of Dysmenorrhea in Iranian Women 2016-01-05 anticipated 100 Complete https://irct.ir/trial/49471 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: In this randomized clinical trial, samples will be randomly selected and randomly selected based on a table of random numbers into 4 equal groups of 25, including 3 experimental groups and a control group. In this study, assignment sequencing and preparation Supplemental and placebo packages in similar packages will be done by a person not involved in sampling and data collection. He did not know about the study groups, Blinding description: This study is an RCT (randomized clinical trial) and will be performed on adouble-blind side . In this way, neither the subjects nor the person who will analyze the data will know which drug group and which treatment group received the treatment. 3 The Effect of Vitamin D and Vitamin E on Ameliorating Intensity and Duration of Dysmenorrhea. Intervention 1: Intervention group:Group receiving 50,000 mg of vitamin D gelatin capsule available from a pharmacy for three months to evaluate the duration and severity of dysmenorrhea. Intervention 2: Intervention group:Group receiving vitamin E400 gelatin capsule, made by Dana Company in Iran for three months to evaluate the duration and severity of dysmenorrhea. Intervention 3: Intervention group:Group receiving vitamin D and vitamin E gelatin capsules for three months to evaluate the duration and severity of dysmenorrhea. Intervention 4: Control group: Group receiving placebo for three months to evaluate the duration and severity of dysmenorrhea. Yes - There is a plan to make this available What will be shared: The data related to the participants' file can be accessed by correspondence by e-mail. When: Start the access period 6 months after publication of results To whom: Researchers working in academic and scientific institutions Conditions: The use of data for scientific research on topics related to the objectives of the study is unrestricted. Where to obtain: To the person in charge of scientific response using their email How to obtain: Objectives and proposals should be sent by e-mail upon request by scientific authorities Comments: In order to empower other researchers in the field of obstetrics and gynecology, we are ready to work with respected researchers.
public Tahereh Behroozi Lak
Urmia, Resalat Blvd, the end of Jahad St, Research ward, Setad, Urmia University of Medical Sciences
Urmia Iran (Islamic Republic of) 5714783734 +98 44 3223 7707 t.behrooz2@yahoo.com Oroumia University of Medical Sciences scientific Tahereh Behroozi Lak
Urmia, Resalat Blvd, the end of Jahad St, Research ward, Setad, Urmia University of Medical Sciences
Urmia Iran (Islamic Republic of) 5714783734 +98 44 3224 0166 t.behrooz2@yahoo.com Educational and Treatment Kowsar Center Iran (Islamic Republic of) Being within the age group of 18-50 years Were no present history of gynecologic or psychological diseases, no urogenital disorders No usage of herbal remedies No history of coagulation disordersand No history of iregular menstrual cycles No history of pelvic or abdominal surgery 18 years 50 years Female Individuals with a history of specific illness Individuals with a history of forced drug use Individuals with a history of symptoms such as burning, itching, discharge, Individuals with a history of irregular periods Treatment - Drugs Treatment - Drugs Treatment - Drugs Treatment - Drugs Intervention group:Group receiving 50,000 mg of vitamin D gelatin capsule available from a pharmacy for three months to evaluate the duration and severity of dysmenorrhea Intervention group:Group receiving vitamin E400 gelatin capsule, made by Dana Company in Iran for three months to evaluate the duration and severity of dysmenorrhea Intervention group:Group receiving vitamin D and vitamin E gelatin capsules for three months to evaluate the duration and severity of dysmenorrhea Control group: Group receiving placebo for three months to evaluate the duration and severity of dysmenorrhea Pain duration. Timepoint: Once before giving the desired treatments and placebo and once after a month and finally two months of continuous use of drugs and placebo. Method of measurement: Cox Menstrual Symptom Scale Questionnaires. Severity of the pain. Timepoint: Once before giving the desired treatments and placebo and once after a month and finally two months of continuous use of drug and placebo. Method of measurement: Visual Analog Scale(VAS) Questionnaires. Time to start pain. Timepoint: Monthly. Method of measurement: Questionnaire before and after menstruation. Menstrual status. Timepoint: Monthly. Method of measurement: Questionnaire. Oroumia University of Medical Sciences Approved 2015-08-25 Ethics committee of Urmia University of Medical Sciens Urmia, Resalat Blvd, the end of Jahad St, Research ward, Setad, Urmia university of medical sciens Urmia West Azarbaijan Iran (Islamic Republic of)